Results 131 to 140 of about 384,301 (315)
Navigating adverse immunostimulation: A practical guide for clinical researchers
Problem Setting As drug development moves towards more complex products, early clinical development programmes are increasingly hampered by unwanted and/or unexpected activation of the immune system (adverse immune stimulation, AIS). Solution At the Centre for Human Drug Research, we have introduced standardized procedures to make AIS manageable, while
Juliette A. van den Noort +3 more
wiley +1 more source
Development of an Initial Screening Scale to Detect Patients With Chest Pain From Acute Coronary Syndrome in the Emergency Department [PDF]
Kyeongmin Jang, Kwisoon Choe
openalex +1 more source
Non-cardiac chest pain: time to extend the rapid access chest pain clinic? [PDF]
John B. Chambers +3 more
openalex +1 more source
Problem setting The emergence of therapeutic proteins has coincided with an increase of acute adverse immunostimulation (AIS). AIS has occured in clinical trials despite compliance with regulatory guidelines on preclinical evaluation and its incidence is anticipated to increase even further.
Juliette A. van den Noort +8 more
wiley +1 more source
Chronic Coronary Syndromes with/without obstructive coronary arteries: are there differences in ongoing chest pain? [PDF]
S. La +10 more
openalex +1 more source
Man With Dyspnea and Chest Pain. [PDF]
Chen CC.
europepmc +1 more source
Polyostotic fibrous dysplasia of the ribs: An unusual cause of chest pain and dyspnea
Serhat Findik
openalex +2 more sources
Fiber‐type soft bioelectronics for wearable and implantable sensing and therapy
Fiber‐type soft bioelectronics are emerging as versatile platforms for wearable and implantable health monitoring and therapeutic applications. These bioelectronics use organic and inorganic matrices combined with advanced fillers, which feature high conductivity, electrochemical sensitivity, softness, and biocompatibility.
Haneul Kim +5 more
wiley +1 more source

